Pharma's Almanac | Process Development (2)

49 Articles Available

2 3

Translational Pharmaceutics

Measuring the Time and Cost Benefits of Integrated Product Development

PAP-Q4-19-CL-017

Strategic Partnership

Partnering for Success from Concept to Commercialization

PAP-Q4-19-CL-010

Capacity Expansion

Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L

PR-M04-19-NI-057

Process Development

Overcoming Challenges in Microbial Process Development

PAP-Q1-2019-CL-010

Process Development

Process Understanding Central to Successful Drug Synthesis

PAP-Q1-2019-CL-025

Process Development

Seven Trends Impacting Chemical Process Development

PAO-M09-18-CL-004

Innovation

Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System for Perfusion Culture

PR-M03-18-NI-070

Partnership

Alcami to Produce Clinical Supplies of Darinaparsin for Solasia

PAO-M11-17-NI-042

Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

PAO-M11-17-NI-029

Cell and Gene Therapy

Segregation in the Design of Gene Therapy Manufacturing Facilities

PAP-Q4-17-CL-002

API

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

PAP-Q4-17-CL-003

Facilities for the Future

PTV-M01-17-NS-012

Designing a Better Single-Use Facility

PAP-Q1-17-CL-012

Investing for Successful Advancement of Viral Vector Manufacturing

PAP-Q1-17-CL-007

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001

Speed-to-Market: Process and Capacity on Demand

PAP-Q04-16-CL-014

Q: What Are You Doing to Become a Premier Outsourcing Partner in the Context of FDA’s Recent Shift to a Focus on Quality Culture Rather than Just Metrics?

PAP-Q04-16-RT-002

Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services

PAP-Q04-16-CL-012

Achieving Continuous Downstream Bioprocessing

PAP-Q04-16-CL-009

Accelerating Approval and Reducing Costs of Spray Dried Drugs through Development by Design (DbD)

PAP-Q03-16-CL-011

Growing Demand for Small-Molecule CDMO Services

PAP-Q1-16-CL-004

Single-Use Now Key Technology in Biopharmaceutical Manufacturing

POP-M01-16-NI-001

What Does It Mean to be a Full-Service CDMO?

PAP-Q4-15-CL-002

Biotherapeutics Outpace Conventional Therapies

BIO-M03-12-NI-001

2 3

Process Development (2)

49 Articles Available

Can't find what you're looking for? Try our advanced search.

Translational Pharmaceutics

Measuring the Time and Cost Benefits of Integrated Product Development

Strategic Partnership

Partnering for Success from Concept to Commercialization

Capacity Expansion

Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L

Process Development

Overcoming Challenges in Microbial Process Development

Process Development

Process Understanding Central to Successful Drug Synthesis

Process Development

Seven Trends Impacting Chemical Process Development

Innovation

Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System for Perfusion Culture

Partnership

Alcami to Produce Clinical Supplies of Darinaparsin for Solasia

Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

Cell and Gene Therapy

Segregation in the Design of Gene Therapy Manufacturing Facilities

API

Achieving Efficient Pharmaceutical Synthesis with Process Intensification

Facilities for the Future

Designing a Better Single-Use Facility

Investing for Successful Advancement of Viral Vector Manufacturing

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

Speed-to-Market: Process and Capacity on Demand

Q: What Are You Doing to Become a Premier Outsourcing Partner in the Context of FDA’s Recent Shift to a Focus on Quality Culture Rather than Just Metrics?

Achieving Successful Treatment Outcomes Through the Delivery of Manufacturing Services

Achieving Continuous Downstream Bioprocessing

Accelerating Approval and Reducing Costs of Spray Dried Drugs through Development by Design (DbD)

Growing Demand for Small-Molecule CDMO Services

Single-Use Now Key Technology in Biopharmaceutical Manufacturing

What Does It Mean to be a Full-Service CDMO?

Biotherapeutics Outpace Conventional Therapies